We offer iDDS probes for species-specific markers of six common bacteria found in bacterial meningitis and bacterial sepsis.
This iDDS probe assay detects the +93 single nucleotide polymorphism in the uidA gene of the highly pathogenic E. coli O157: H7 strain.
Our iDDS probe assays for gram-negative and gram-positive bacteria enable accurate discrimination in a complex matrix, such as cerebrospinal fluid.
We offer iDDS probes for detecting >20 mutations conferring isoniazid and rifampicin drug-resistance to MTB. We also offer iDDS probes for MTB and M. avium.
We have developed iDDS probes for the C2611T mutation of 23S rRNA associated with macrolide resistance in N. gonorrhoeae. We have also developed an iDDS probe for the wild-type sequence.
VRE is the second-leading cause of drug-resistant nosocomial infections. Our dual-iDDS probe assay for VRE simultaneously detects the vanA gene of E. faecium at two different sites.